Search
Isospaglumic acid
go.drugbank.com/drugs/DB19650InvestigationalIsospaglumic acid has a monoisotopic molecular weight of 304.09 Da. … Isospaglumic acid is a small molecule drug.
Izumerogant
go.drugbank.com/drugs/DB21604ExperimentalIzumerogant has a monoisotopic molecular weight of 495.11 Da. … Izumerogant is a small molecule drug.
Glovadalen
go.drugbank.com/drugs/DB21709InvestigationalGlovadalen has a monoisotopic molecular weight of 475.14 Da. … Glovadalen is a small molecule drug.
Iopromide
go.drugbank.com/drugs/DB09156ApprovedIopromide is a low osmolar, non-ionic X-ray contrast agent for intravascular administration. … favorable safety profile, with only 0.7% of patients in a 2 years study experiencing adverse events.
Categories: Compounds used in a research, industrial, or household settingThyrotropin alfa
go.drugbank.com/drugs/DB00024ApprovedInvestigationalVet approvedIt is a heterodimeric glycoprotein comprised of two non-covalently linked subunits, an alpha subunit of 92 amino acid residues containing two N-linked glycosylation sites and a beta subunit of 112 residues … which is the effector region responsible for the stimulation of adenylate cyclase, displays close structural similarity with the alpha subunit of human chorionic gonadotropin (hCG), luteinizing hormone (LH
Faxeladol
go.drugbank.com/drugs/DB20529InvestigationalFaxeladol has a monoisotopic molecular weight of 233.18 Da. … Faxeladol is a small molecule drug. The usage of the INN stem '-adol/-adol-' in the name indicates that Faxeladol is a analgesic.
Vevorisertib
go.drugbank.com/drugs/DB21481InvestigationalVevorisertib has a monoisotopic molecular weight of 586.32 Da. … Vevorisertib is a small molecule drug. The usage of the INN stem '-sertib' in the name indicates that Vevorisertib is a serine/threonine kinase inhibitor.
Flizasertib
go.drugbank.com/drugs/DB21613InvestigationalFlizasertib has a monoisotopic molecular weight of 271.11 Da. … Flizasertib is a small molecule drug. The usage of the INN stem '-sertib' in the name indicates that Flizasertib is a serine/threonine kinase inhibitor.
SX-682
go.drugbank.com/drugs/DB19210Investigationalclinical trial NCT04574583 (Phase I/II Trial Investigating the Safety, Tolerability, Pharmacokinetics, Immune and Clinical Activity of SX-682 in Combination With Bintrafusp Alfa (M7824 or Tgf-beta "Trap"/pd-l1
CYT007-TNFQb
go.drugbank.com/drugs/DB05758ExperimentalCYT007-TNFQb is an active immunization therapy that aims at providing a novel treatment to people suffering from RA or psoriasis.